home > drugs a-z list > follistim aq cartridge (follitropin beta injection) drug center > follistim aq cartridge (follitropin beta injection) drug - overdosage and contraindications

Aside from the possibility of Ovarian Hyperstimulation Syndrome [see WARNINGS AND PRECAUTIONS] and multiple gestations [see WARNINGS AND PRECAUTIONS], there is no additional information concerning the consequences of acute overdosage with Follistim AQ Cartridge.

Follistim AQ Cartridge is contraindicated in women and men who exhibit:

• Prior hypersensitivity to recombinant hFSH products
• High levels of FSH indicating primary gonadal failure
• Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders) [see INDICATIONS AND USAGE]
• Hypersensitivity reactions to streptomycin or neomycin. Follistim AQ may contain traces of these antibiotics
• Tumors of the ovary, breast, uterus, testis, hypothalamus or pituitary gland

Follistim AQ Cartridge is also contraindicated in women who exhibit:

• Pregnancy [see Use In Specific Populations]
• Heavy or irregular vaginal bleeding of undetermined origin
• Ovarian cysts or enlargement not due to polycystic ovary syndrome (PCOS)

Last reviewed on RxList: 9/6/2011
This monograph has been modified to include the generic and brand name in many instances.